{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:19:24Z","timestamp":1788607164953,"version":"build-2803163510"},"reference-count":207,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_173224\/1"],"award-info":[{"award-number":["31003A_173224\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-3487-08-2014"],"award-info":[{"award-number":["KFS-3487-08-2014"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbagrm.2020.194550","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T02:42:27Z","timestamp":1587264147000},"page":"194550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Learning from mouse models of MLL fusion gene-driven acute leukemia"],"prefix":"10.1016","volume":"1863","author":[{"given":"Juerg","family":"Schwaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagrm.2020.194550_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.me.36.020185.002351","article-title":"The relation of oncogenesis and cytogenetics in leukemia and lymphoma","volume":"36","author":"Pearson","year":"1985","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.genet.32.1.495","article-title":"The critical role of chromosome translocations in human leukemias","volume":"32","author":"Rowley","year":"1998","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0076-6879(83)01031-9","article-title":"Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection","volume":"101","author":"Gordon","year":"1983","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V89.2.376","article-title":"Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences","volume":"89","author":"Grisolano","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0030","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1073\/pnas.94.10.5302","article-title":"Acute leukemia with promyelocytic features in PML\/RARalpha transgenic mice","volume":"94","author":"He","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.bbagrm.2020.194550_bb0035","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.93.15.7900","article-title":"Transgenic expression of PML\/RARalpha impairs myelopoiesis","volume":"93","author":"Early","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0040","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.94.6.2551","article-title":"A PMLRARalpha transgene initiates murine acute promyelocytic leukemia","volume":"94","author":"Brown","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(01)00518-0","article-title":"The expression of ETV6\/CBFA2 (TEL\/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo","volume":"130","author":"Andreasson","year":"2001","journal-title":"Cancer Genet. Cytogenet."},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0050","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.V93.5.1707.405k24_1707_1714","article-title":"TEL\/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor","volume":"93","author":"Tomasson","year":"1999","journal-title":"Blood"},{"issue":"4944","key":"10.1016\/j.bbagrm.2020.194550_bb0055","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.176.4.1149","article-title":"Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus","volume":"176","author":"Hawley","year":"1992","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0065","first-page":"136","article-title":"Versatile retroviral vectors for potential use in gene therapy","volume":"1","author":"Hawley","year":"1994","journal-title":"Gene Ther."},{"issue":"15","key":"10.1016\/j.bbagrm.2020.194550_bb0070","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1128\/MCB.22.15.5506-5517.2002","article-title":"Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation","volume":"22","author":"de Guzman","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0075","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1309\/H8JH6L094B9U3HGT","article-title":"t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia","volume":"121","author":"Yin","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2141.2000.02003.x","article-title":"Expression of the NUP98\/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15)","volume":"109","author":"Yamamoto","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0085","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","article-title":"A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9","volume":"99","author":"Dash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bbagrm.2020.194550_bb0090","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2002-04-1244","article-title":"Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system","volume":"100","author":"Mayotte","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.bbagrm.2020.194550_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1471-4914(02)02397-3","article-title":"The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism","volume":"8","author":"Collins","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","article-title":"Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias","volume":"71","author":"Tkachuk","year":"1992","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.bbagrm.2020.194550_bb0115","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1093\/emboj\/16.14.4226","article-title":"Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL","volume":"16","author":"Lavau","year":"1997","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/MCB.18.1.122","article-title":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX","volume":"18","author":"Slany","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"17","key":"10.1016\/j.bbagrm.2020.194550_bb0125","first-page":"6480","article-title":"MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation","volume":"61","author":"Schreiner","year":"2001","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0130","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1206104","article-title":"The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid\/myeloid cell","volume":"22","author":"Zeisig","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1535-6108(03)00214-9","article-title":"Dimerization of MLL fusion proteins immortalizes hematopoietic cells","volume":"4","author":"Martin","year":"2003","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.bbagrm.2020.194550_bb0145","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.190167297","article-title":"Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice","volume":"97","author":"Lavau","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0150","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V99.10.3780","article-title":"The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10","volume":"99","author":"DiMartino","year":"2002","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bbagrm.2020.194550_bb0155","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/MCB.22.18.6542-6552.2002","article-title":"MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function","volume":"22","author":"So","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1535-6108(03)00019-9","article-title":"MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice","volume":"3","author":"So","year":"2003","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.bbagrm.2020.194550_bb0165","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/emboj\/19.17.4655","article-title":"Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia","volume":"19","author":"Lavau","year":"2000","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.bbagrm.2020.194550_bb0170","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/MCB.21.16.5678-5687.2001","article-title":"The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis","volume":"21","author":"Luo","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"24","key":"10.1016\/j.bbagrm.2020.194550_bb0175","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1101\/gad.1143403","article-title":"Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors","volume":"17","author":"Cozzio","year":"2003","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0180","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2003-10-3722","article-title":"Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9","volume":"103","author":"So","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI200522725","article-title":"Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis","volume":"115","author":"Ono","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7104","key":"10.1016\/j.bbagrm.2020.194550_bb0190","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0195","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood-2003-11-3817","article-title":"The small oligomerization domain of gephyrin converts MLL to an oncogene","volume":"103","author":"Eguchi","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2009-09-243386","article-title":"Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6","volume":"116","author":"Liedtke","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0205","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3324\/haematol.2017.169789","article-title":"MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development","volume":"102","author":"Kim","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood-2002-06-1785","article-title":"Common mechanism for oncogenic activation of MLL by forkhead family proteins","volume":"101","author":"So","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.neo.2019.03.006","article-title":"Ets1 plays a critical role in MLL\/EB1-mediated leukemic transformation in a mouse bone marrow transplantation model","volume":"21","author":"Fu","year":"2019","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0220","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.leu.2403321","article-title":"Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein","volume":"18","author":"Caslini","year":"2004","journal-title":"Leukemia"},{"issue":"39","key":"10.1016\/j.bbagrm.2020.194550_bb0225","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1073\/pnas.0506464102","article-title":"The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression","volume":"102","author":"Xia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.bbagrm.2020.194550_bb0230","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","article-title":"The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4","volume":"115","author":"Bursen","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0235","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"P. St. Jude Children\u2019s Research Hospital-Washington University pediatric cancer genome, the landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.bbagrm.2020.194550_bb0240","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.3371","article-title":"The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias","volume":"47","author":"Lavallee","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.leu.2404951","article-title":"MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment","volume":"22","author":"Stubbs","year":"2008","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bbagrm.2020.194550_bb0250","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2009.177","article-title":"Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation","volume":"23","author":"Ono","year":"2009","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.bbagrm.2020.194550_bb0255","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2013-08-521708","article-title":"NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia","volume":"124","author":"Sachs","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0260","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41467-018-04180-1","article-title":"De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia","volume":"9","author":"Hyrenius-Wittsten","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0265","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41375-018-0253-3","article-title":"Molecular pathogenesis of disease progression in MLL-rearranged AML","volume":"33","author":"Kotani","year":"2019","journal-title":"Leukemia"},{"issue":"5824","key":"10.1016\/j.bbagrm.2020.194550_bb0270","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.bbagrm.2020.194550_bb0275","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia","volume":"117","author":"Montes","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0280","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-15-2769","article-title":"Activated KRAS cooperates with MLL-AF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia","volume":"76","author":"Prieto","year":"2016","journal-title":"Cancer Res."},{"issue":"47","key":"10.1016\/j.bbagrm.2020.194550_bb0285","doi-asserted-by":"crossref","first-page":"81936","DOI":"10.18632\/oncotarget.19567","article-title":"The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34(+) cells","volume":"8","author":"Prieto","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0290","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","article-title":"Instructive role of MLL-fusion proteins revealed by a model of t(4;11) pro-B acute lymphoblastic leukemia","volume":"30","author":"Lin","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbagrm.2020.194550_bb0295","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood-2017-04-777185","article-title":"The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment","volume":"130","author":"Lin","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037892","article-title":"Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice","volume":"7","author":"Moriya","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0305","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.bbagrm.2020.194550_bb0310","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/emboj\/18.13.3564","article-title":"The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis","volume":"18","author":"Dobson","year":"1999","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0315","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/emboj\/19.5.843","article-title":"Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene","volume":"19","author":"Dobson","year":"2000","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0320","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","article-title":"A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0325","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/sj.leu.2404342","article-title":"The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice","volume":"20","author":"Kong","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0330","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccr.2012.01.021","article-title":"DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo","volume":"21","author":"Takacova","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0335","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/nar\/23.10.1686","article-title":"A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins","volume":"23","author":"Littlewood","year":"1995","journal-title":"Nucleic Acids Res."},{"issue":"7520","key":"10.1016\/j.bbagrm.2020.194550_bb0340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13483","article-title":"DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier","volume":"514","author":"Santos","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0345","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2014.10.036","article-title":"Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation","volume":"9","author":"Ugale","year":"2014","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","article-title":"MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome","volume":"30","author":"Stavropoulou","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0355","doi-asserted-by":"crossref","unstructured":"V. Stavropoulou, Almosailleakh, M., Royo, H., Spetz, J-F., Juge, S., Brault, L., Kopp, P., Iacovino, M., Kyba, M., Tzankov, A., Stadler, M., Cazzaniga, G., Peters, Antoine H.F.M., Schwaller, J., A novel inducible mouse model of MLL-ENL-driven mixed lineage leukemia Hemasphere 2(4) (2018) e51.","DOI":"10.1097\/HS9.0000000000000051"},{"issue":"17","key":"10.1016\/j.bbagrm.2020.194550_bb0360","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/sj.emboj.7600760","article-title":"Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis","volume":"24","author":"Drynan","year":"2005","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nmeth727","article-title":"The invertor knock-in conditional chromosomal translocation mimic","volume":"2","author":"Forster","year":"2005","journal-title":"Nat. Methods"},{"issue":"22","key":"10.1016\/j.bbagrm.2020.194550_bb0370","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","article-title":"A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology","volume":"25","author":"Metzler","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0380","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.gde.2019.04.001","article-title":"Engineering CRISPR mouse models of cancer","volume":"54","author":"Weber","year":"2019","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"14","key":"10.1016\/j.bbagrm.2020.194550_bb0385","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood-2015-05-646398","article-title":"MLL leukemia induction by genome editing of human CD34+ hematopoietic cells","volume":"126","author":"Buechele","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0390","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/bloodadvances.2017013748","article-title":"MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing","volume":"2","author":"Schneidawind","year":"2018","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.bbagrm.2020.194550_bb0395","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3324\/haematol.2017.164046","article-title":"CRISPR-Cas9-induced t(11;19)\/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo","volume":"102","author":"Reimer","year":"2017","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.bbagrm.2020.194550_bb0400","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/bloodadvances.2019000450","article-title":"High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells","volume":"3","author":"Jeong","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0405","first-page":"14","article-title":"Murine retrovirally-transduced bone marrow engraftment models of MLL-fusion-driven Acute Myelogenous Leukemias (AML)","volume":"78","author":"Stubbs","year":"2017","journal-title":"Curr Protoc Pharmacol"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0410","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOH.0000000000000245","article-title":"Deregulation of the HOXA9\/MEIS1 axis in acute leukemia","volume":"23","author":"Collins","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"18","key":"10.1016\/j.bbagrm.2020.194550_bb0415","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.1111603","article-title":"Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9","volume":"17","author":"Ayton","year":"2003","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0420","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2003-10-3722","article-title":"Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9","volume":"103","author":"So","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0425","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2003-07-2582","article-title":"Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia","volume":"103","author":"Kumar","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0430","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bbagrm.2020.194550_bb0435","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1101\/gad.1602107","article-title":"Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential","volume":"21","author":"Wong","year":"2007","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0440","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2008-06-163287","article-title":"A role for MEIS1 in MLL-fusion gene leukemia","volume":"113","author":"Kumar","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0445","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ijc.30739","article-title":"PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia","volume":"141","author":"Guo","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0450","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood-2011-03-341081","article-title":"Identification and characterization of Hoxa9 binding sites in hematopoietic cells","volume":"119","author":"Huang","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0455","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20130932","article-title":"Initiation of MLL-rearranged AML is dependent on C\/EBPalpha","volume":"211","author":"Ohlsson","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0460","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.stem.2015.08.011","article-title":"Hematopoietic differentiation is required for initiation of acute myeloid leukemia","volume":"17","author":"Ye","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.bbagrm.2020.194550_bb0465","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/leu.2013.384","article-title":"PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS\/HOX pathway","volume":"28","author":"Zhou","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cas.12593","article-title":"Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells","volume":"106","author":"Aikawa","year":"2015","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.bbagrm.2020.194550_bb0475","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2010-10-315440","article-title":"Loss of AML1\/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF","volume":"118","author":"Nishimoto","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbagrm.2020.194550_bb0480","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1172\/JCI68557","article-title":"Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells","volume":"123","author":"Goyama","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0485","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood-2013-03-489575","article-title":"Downregulation of RUNX1\/CBFbeta by MLL fusion proteins enhances hematopoietic stem cell self-renewal","volume":"123","author":"Zhao","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0490","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0495","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026658","article-title":"Mixed-lineage leukemia fusions and chromatin in leukemia","volume":"7","author":"Krivtsov","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0500","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2015.04.004","article-title":"Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential","volume":"11","author":"Kuntimaddi","year":"2015","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0505","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ccell.2014.10.009","article-title":"AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes","volume":"26","author":"Deshpande","year":"2014","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.bbagrm.2020.194550_bb0510","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1158\/0008-5472.CAN-10-3294","article-title":"Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bbagrm.2020.194550_bb0515","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0520","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1016\/j.bbagrm.2020.194550_bb0525","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1182\/blood-2011-02-334359","article-title":"DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0530","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0535","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.bbagrm.2020.194550_bb0540","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bbagrm.2020.194550_bb0545","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0550","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0555","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.bbagrm.2020.194550_bb0560","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.M111.258186","article-title":"Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein","volume":"286","author":"Murai","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0565","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0570","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","article-title":"Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo","volume":"27","author":"Borkin","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0575","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","article-title":"A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia","volume":"36","author":"Krivtsov","year":"2019","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0580","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","article-title":"Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia","volume":"6","author":"Kuhn","year":"2016","journal-title":"Cancer Discov"},{"issue":"6477","key":"10.1016\/j.bbagrm.2020.194550_bb0585","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.aax5863","article-title":"Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia","volume":"367","author":"Uckelmann","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0590","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI129126","article-title":"Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia","volume":"130","author":"Klossowski","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0595","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2008.05.003","article-title":"Menin critically links MLL proteins with LEDGF on cancer-associated target genes","volume":"14","author":"Yokoyama","year":"2008","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0600","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/leu.2013.10","article-title":"Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF\/p75)","volume":"27","author":"Mereau","year":"2013","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.bbagrm.2020.194550_bb0605","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2014-01-550079","article-title":"The same site on the integrase-binding domain of lens epithelium-derived growth factor is a therapeutic target for MLL leukemia and HIV","volume":"124","author":"Murai","year":"2014","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bbagrm.2020.194550_bb0610","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1158\/0008-5472.CAN-13-3602","article-title":"Validation and structural characterization of the LEDGF\/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia","volume":"74","author":"Cermakova","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0615","first-page":"95","article-title":"LEDGF\/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis","volume":"131","author":"El Ashkar","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0620","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrc2931","article-title":"Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins","volume":"10","author":"Mills","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0625","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MOH.0b013e328338c439","article-title":"Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells","volume":"17","author":"Schuringa","year":"2010","journal-title":"Curr. Opin. Hematol."},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0630","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2011.85","article-title":"Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells","volume":"25","author":"Yuan","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0635","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2011.05.004","article-title":"Functional crosstalk between Bmi1 and MLL\/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells","volume":"8","author":"Smith","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"13","key":"10.1016\/j.bbagrm.2020.194550_bb0640","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0645","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2011.09.008","article-title":"CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis","volume":"20","author":"Tan","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0650","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2017-11-815035","article-title":"The interaction of ENL with PAF1 mitigates polycomb silencing and facilitates murine leukemogenesis","volume":"131","author":"Hetzner","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0655","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccr.2010.04.012","article-title":"The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis","volume":"17","author":"Muntean","year":"2010","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bbagrm.2020.194550_bb0660","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.1202258109","article-title":"Polycomb repressive complex 2 is required for MLL-AF9 leukemia","volume":"109","author":"Neff","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0665","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0670","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1084\/jem.20181276","article-title":"Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML","volume":"216","author":"Basheer","year":"2019","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bbagrm.2020.194550_bb0675","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/onc.2012.110","article-title":"The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia","volume":"32","author":"Shi","year":"2013","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0680","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/cas.12386","article-title":"Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16","volume":"105","author":"Ueda","year":"2014","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0685","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer","volume":"9","author":"Kim","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0690","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2014-06-581082","article-title":"Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia","volume":"125","author":"Xu","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0695","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0092-8674(91)90099-K","article-title":"A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis","volume":"65","author":"Mucenski","year":"1991","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0700","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2005-12-5014","article-title":"c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells","volume":"108","author":"Hess","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0705","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","article-title":"Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells","volume":"4","author":"Somervaille","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0710","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI38030","article-title":"C-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis","volume":"120","author":"Jin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.bbagrm.2020.194550_bb0715","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1101\/gad.17269211","article-title":"An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance","volume":"25","author":"Zuber","year":"2011","journal-title":"Genes Dev."},{"issue":"17","key":"10.1016\/j.bbagrm.2020.194550_bb0720","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2012-02-413187","article-title":"Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes","volume":"123","author":"Pattabiraman","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0725","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56426-7","article-title":"The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein","volume":"9","author":"Cao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0730","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exphem.2016.12.003","article-title":"Targeting the transcription factor Myb by small-molecule inhibitors","volume":"47","author":"Uttarkar","year":"2017","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0735","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/leu.2017.317","article-title":"Targeting acute myeloid leukemia by drug-induced c-MYB degradation","volume":"32","author":"Walf-Vorderwulbecke","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0740","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41467-017-02618-6","article-title":"Peptidomimetic blockade of MYB in acute myeloid leukemia","volume":"9","author":"Ramaswamy","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0745","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00277-013-1803-4","article-title":"MicroRNAs mark in the MLL-rearranged leukemia","volume":"92","author":"Benetatos","year":"2013","journal-title":"Ann. Hematol."},{"issue":"14","key":"10.1016\/j.bbagrm.2020.194550_bb0750","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0755","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1084\/jem.20171312","article-title":"miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential","volume":"215","author":"Meyer","year":"2018","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bbagrm.2020.194550_bb0760","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","article-title":"Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia","volume":"107","author":"Mi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"28","key":"10.1016\/j.bbagrm.2020.194550_bb0765","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1073\/pnas.1310144110","article-title":"miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0770","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood-2016-06-721027","article-title":"miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism","volume":"129","author":"Liu","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbagrm.2020.194550_bb0775","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.exphem.2016.08.012","article-title":"MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development","volume":"44","author":"Schneider","year":"2016","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0780","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2012.08.028","article-title":"Blockade of miR-150 maturation by MLL-fusion\/MYC\/LIN-28 is required for MLL-associated leukemia","volume":"22","author":"Jiang","year":"2012","journal-title":"Cancer Cell"},{"issue":"47","key":"10.1016\/j.bbagrm.2020.194550_bb0785","doi-asserted-by":"crossref","first-page":"19397","DOI":"10.1073\/pnas.1217519109","article-title":"MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0790","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","article-title":"Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells","volume":"13","author":"Chen","year":"2008","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0795","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/leu.2012.363","article-title":"Cell of origin determines clinically relevant subtypes of MLL-rearranged AML","volume":"27","author":"Krivtsov","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0800","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12166","article-title":"Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells","volume":"7","author":"George","year":"2016","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.bbagrm.2020.194550_bb0805","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.15252\/embj.201797994","article-title":"Transcriptional memory of cells of origin overrides beta-catenin requirement of MLL cancer stem cells","volume":"36","author":"Siriboonpiputtana","year":"2017","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0810","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/bloodadvances.2018022400","article-title":"Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells","volume":"3","author":"Dong","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0815","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/leu.2012.343","article-title":"MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny","volume":"27","author":"Horton","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0820","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/HS9.0000000000000152","article-title":"The impact of the cellular origin in acute myeloid leukemia: learning from mouse models","volume":"3","author":"Fisher","year":"2019","journal-title":"Hemasphere"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb0825","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.blre.2017.03.004","article-title":"The bone marrow microenvironment - home of the leukemic blasts","volume":"31","author":"Shafat","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0830","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fonc.2018.00444","article-title":"Acute myeloid leukemia and the bone marrow niche-take a closer look","volume":"8","author":"Behrmann","year":"2018","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0835","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.bbagrm.2020.194550_bb0840","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood-2011-03-345165","article-title":"Differential niche and Wnt requirements during acute myeloid leukemia progression","volume":"118","author":"Lane","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb0845","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0850","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.bbagrm.2020.194550_bb0855","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/bloodadvances.2017013870","article-title":"Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"issue":"7648","key":"10.1016\/j.bbagrm.2020.194550_bb0860","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature21693","article-title":"Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis","volume":"544","author":"Herault","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0865","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0870","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20181765","article-title":"The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia","volume":"216","author":"Rowe","year":"2019","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0875","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/leu.2013.374","article-title":"In vivo eradication of MLL\/ENL leukemia cells by NK cells in the absence of adaptive immunity","volume":"28","author":"Nakata","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0880","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2017.11.003","article-title":"Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia","volume":"93","author":"Yang","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0885","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(03)88255-6","article-title":"Retroviral insertional mutagenesis: tagging cancer pathways","volume":"88","author":"Mikkers","year":"2003","journal-title":"Adv. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbagrm.2020.194550_bb0890","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.leu.2401852","article-title":"Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies","volume":"14","author":"Largaespada","year":"2000","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.bbagrm.2020.194550_bb0895","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2010-04-281428","article-title":"An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model","volume":"119","author":"Bergerson","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbagrm.2020.194550_bb0900","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2005-03-1113","article-title":"Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells","volume":"106","author":"Du","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0905","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/leu.2009.272","article-title":"Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia","volume":"24","author":"Liu","year":"2010","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0910","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI80825","article-title":"MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia","volume":"126","author":"Riedel","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagrm.2020.194550_bb0915","article-title":"MN1 is indispensable for MLL-rearranged acute myeloid leukemia","author":"Sharma","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0920","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/gcc.20950","article-title":"Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia","volume":"51","author":"Haferlach","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"7370","key":"10.1016\/j.bbagrm.2020.194550_bb0925","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"issue":"7370","key":"10.1016\/j.bbagrm.2020.194550_bb0930","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0935","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm.2016.143","article-title":"Functions of bromodomain-containing proteins and their roles in homeostasis and cancer","volume":"18","author":"Fujisawa","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0940","doi-asserted-by":"crossref","unstructured":"A.G. Cochran, A.R. Conery, R.J. Sims, 3rd, Bromodomains: a new target class for drug development, Nat. Rev. Drug Discov. 18(8) (2019) 609\u2013628.","DOI":"10.1038\/s41573-019-0030-7"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0945","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb0950","doi-asserted-by":"crossref","first-page":"FSO372","DOI":"10.4155\/fsoa-2018-0115","article-title":"Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy","volume":"5","author":"Alqahtani","year":"2019","journal-title":"Future Sci OA"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0955","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/S2352-3026(15)00247-1","article-title":"Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study","volume":"3","author":"Berthon","year":"2016","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0960","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2013.05.004","article-title":"In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling","volume":"24","author":"Miller","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb0965","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccr.2009.08.018","article-title":"Proteomic and genetic approaches identify Syk as an AML target","volume":"16","author":"Hahn","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0970","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccr.2014.01.022","article-title":"SYK is a critical regulator of FLT3 in acute myeloid leukemia","volume":"25","author":"Puissant","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagrm.2020.194550_bb0975","series-title":"High Response Rates with Entospetinib in Pateints with t(v;11q23.2);KMT2A Rearranged Acute Myeloid and Acute Lymphoblastic Leukemia","first-page":"208","author":"Walker","year":"2018"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb0980","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-02-558114","article-title":"Requirement for CDK6 in MLL-rearranged acute myeloid leukemia","volume":"124","author":"Placke","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbagrm.2020.194550_bb0985","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nbt.3235","article-title":"Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains","volume":"33","author":"Shi","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb0990","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/leu.2017.206","article-title":"Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML","volume":"32","author":"Kaushik","year":"2018","journal-title":"Leukemia"},{"issue":"46","key":"10.1016\/j.bbagrm.2020.194550_bb0995","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1038\/s41388-019-0937-9","article-title":"Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPER\/Cas9","volume":"38","author":"Secker","year":"2019","journal-title":"Oncogene"},{"issue":"7683","key":"10.1016\/j.bbagrm.2020.194550_bb1000","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbagrm.2020.194550_bb1005","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)a)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbagrm.2020.194550_bb1010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb1015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbagrm.2020.194550_bb1020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tig.2019.10.011","article-title":"The biogenesis and precise control of RNA m(6)a methylation","volume":"36","author":"Huang","year":"2020","journal-title":"Trends Genet."},{"issue":"4","key":"10.1016\/j.bbagrm.2020.194550_bb1025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-17-1271","article-title":"MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia","volume":"8","author":"Brown","year":"2018","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.bbagrm.2020.194550_bb1030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ccell.2018.01.012","article-title":"Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS","volume":"33","author":"Yamauchi","year":"2018","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bbagrm.2020.194550_bb1035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cell.2018.01.032","article-title":"A non-catalytic function of SETD1A regulates cyclin K and the DNA damage response","volume":"172","author":"Hoshii","year":"2018","journal-title":"Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939919303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874939919303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:29:03Z","timestamp":1761744543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874939919303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":207,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1874939919303487"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagrm.2020.194550","relation":{},"ISSN":["1874-9399"],"issn-type":[{"value":"1874-9399","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learning from mouse models of MLL fusion gene-driven acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagrm.2020.194550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"194550"}}